Heterogeneity of thyroid cancer

E Chmielik, D Rusinek, M Oczko-Wojciechowska… - Pathobiology, 2018 - karger.com
There are 5 main histological types of thyroid cancers (TCs): papillary, follicular (also known
as differentiated), poorly differentiated, anaplastic (the most aggressive form), and medullary …

Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance

G Acquaviva, M Visani, A Repaci, KJ Rhoden… - …, 2018 - Wiley Online Library
Thyroid cancer is the most common endocrine malignancy. Knowledge of the molecular
pathology of thyroid tumours originating from follicular cells has greatly advanced in the past …

Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers

N Pozdeyev, LM Gay, ES Sokol, R Hartmaier… - Clinical Cancer …, 2018 - AACR
Purpose: To define the genetic landscape of advanced differentiated and anaplastic thyroid
cancer (ATC) and identify genetic alterations of potential diagnostic, prognostic, and …

MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN

J Ramirez-Moya, L Wert-Lamas, P Santisteban - Oncogene, 2018 - nature.com
Recent studies have shown that miR-146b is the most upregulated microRNA in thyroid
cancer and has a central role in cancer progression through mechanisms that remain largely …

Cancer molecular markers: A guide to cancer detection and management

M Nair, SS Sandhu, AK Sharma - Seminars in cancer biology, 2018 - Elsevier
Cancer is generally caused by the molecular alterations which lead to specific mutations.
Advances in molecular biology have provided an impetus to the study of cancers with …

[HTML][HTML] Treatment of refractory thyroid cancer

A Berdelou, L Lamartina, M Klain… - Endocrine-related …, 2018 - erc.bioscientifica.com
Distant metastases from thyroid cancer of follicular origin are uncommon. Treatment
includes levothyroxine administration, focal treatment modalities with surgery, external …

Tipifarnib inhibits HRAS-driven dedifferentiated thyroid cancers

BR Untch, V Dos Anjos, MER Garcia-Rendueles… - Cancer research, 2018 - AACR
Of the three RAS oncoproteins, only HRAS is delocalized and inactivated by
farnesyltransferase inhibitors (FTI), an approach yet to be exploited clinically. In this study …

[HTML][HTML] Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers

JA Knauf, KA Luckett, KY Chen, F Voza… - The Journal of …, 2018 - Am Soc Clin Investig
Anaplastic thyroid carcinomas (ATCs) have a high prevalence of BRAF and TP53 mutations.
A trial of vemurafenib in nonmelanoma BRAFV600E-mutant cancers showed significant …

[HTML][HTML] Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates

N Pstrąg, K Ziemnicka, H Bluyssen, J Wesoły - Molecular cancer, 2018 - Springer
In recent years, thyroid malignances have become more prevalent, especially among
women. The most common sporadic types of thyroid tumors of follicular origin include …

[HTML][HTML] Predictive factors of outcome in poorly differentiated thyroid carcinomas

C de la Fouchardière, M Decaussin-Petrucci… - European Journal of …, 2018 - Elsevier
Background The prognosis of poorly differentiated thyroid carcinomas (PDTC) is
heterogeneous though generally poor. The objectives of this study were to identify clinical …